Bayer CropScience Ltd
Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
- Market Cap ₹ 20,267 Cr.
- Current Price ₹ 4,510
- High / Low ₹ 6,540 / 4,273
- Stock P/E 29.4
- Book Value ₹ 660
- Dividend Yield 2.77 %
- ROCE 29.1 %
- ROE 23.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 74.3%
- Company's working capital requirements have reduced from 75.2 days to 59.8 days
Cons
- The company has delivered a poor sales growth of 5.90% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,660 | 2,769 | 2,803 | 2,710 | 3,167 | 3,609 | 4,261 | 4,734 | 5,140 | 5,106 | 5,473 | 5,675 | |
| 3,144 | 2,334 | 2,389 | 2,300 | 2,684 | 2,883 | 3,450 | 3,923 | 4,216 | 4,147 | 4,783 | 4,801 | |
| Operating Profit | 516 | 435 | 414 | 410 | 483 | 726 | 812 | 812 | 924 | 959 | 691 | 874 |
| OPM % | 14% | 16% | 15% | 15% | 15% | 20% | 19% | 17% | 18% | 19% | 13% | 15% |
| 88 | 82 | 70 | 39 | 51 | -64 | 69 | 112 | 168 | 76 | 118 | 95 | |
| Interest | 5 | 10 | 7 | 11 | 10 | 14 | 13 | 13 | 22 | 20 | 17 | 20 |
| Depreciation | 25 | 25 | 29 | 33 | 44 | 65 | 74 | 64 | 80 | 74 | 85 | 94 |
| Profit before tax | 574 | 482 | 448 | 404 | 480 | 583 | 794 | 847 | 990 | 941 | 707 | 855 |
| Tax % | 33% | 35% | 35% | 26% | 30% | 19% | 38% | 24% | 23% | 21% | 20% | 19% |
| 383 | 315 | 291 | 300 | 337 | 474 | 493 | 645 | 758 | 740 | 568 | 689 | |
| EPS in Rs | 104.59 | 89.13 | 82.31 | 87.41 | 98.18 | 105.58 | 109.72 | 143.58 | 168.71 | 164.77 | 126.38 | 153.35 |
| Dividend Payout % | 20% | 19% | 21% | 21% | 18% | 24% | 105% | 104% | 77% | 85% | 99% | 39% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 3% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 1% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -3% |
| 3 Years: | 2% |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 24% |
| 3 Years: | 23% |
| Last Year: | 24% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 37 | 35 | 35 | 34 | 34 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 1,996 | 1,804 | 2,021 | 1,744 | 2,205 | 2,528 | 2,505 | 2,479 | 2,667 | 2,804 | 2,806 | 2,921 |
| 0 | 0 | 0 | 0 | 0 | 2 | 26 | 86 | 74 | 47 | 105 | 82 | |
| 740 | 597 | 769 | 756 | 1,310 | 1,262 | 1,663 | 1,742 | 1,893 | 1,701 | 2,290 | 2,652 | |
| Total Liabilities | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 | 5,699 |
| 322 | 290 | 342 | 334 | 440 | 468 | 425 | 468 | 462 | 414 | 470 | 581 | |
| CWIP | 1 | 17 | 24 | 36 | 47 | 56 | 76 | 98 | 109 | 119 | 119 | 5 |
| Investments | 29 | 68 | 50 | 0 | 0 | 41 | 52 | 38 | 41 | 54 | 35 | 57 |
| 2,422 | 2,062 | 2,410 | 2,164 | 3,062 | 3,270 | 3,686 | 3,749 | 4,066 | 4,010 | 4,622 | 5,056 | |
| Total Assets | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 | 5,699 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 200 | 206 | 157 | 121 | 433 | 666 | 687 | 216 | 609 | 952 | 262 | 1,078 | |
| 485 | 16 | -8 | 38 | -113 | -29 | 7 | 64 | 83 | 0 | 86 | 72 | |
| -42 | -590 | -73 | -581 | -158 | -148 | -556 | -703 | -613 | -656 | -619 | -624 | |
| Net Cash Flow | 644 | -367 | 76 | -421 | 162 | 489 | 138 | -424 | 79 | 296 | -272 | 527 |
| Free Cash Flow | 297 | 170 | 108 | 80 | 378 | 638 | 656 | 168 | 537 | 912 | 222 | 1,014 |
| CFO/OP | 76% | 86% | 74% | 53% | 132% | 110% | 105% | 59% | 92% | 113% | 61% | 142% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 57 | 53 | 72 | 89 | 81 | 73 | 65 | 77 | 69 | 69 | 63 | 72 |
| Inventory Days | 85 | 169 | 178 | 175 | 294 | 206 | 226 | 235 | 268 | 222 | 319 | 231 |
| Days Payable | 40 | 52 | 67 | 67 | 164 | 101 | 142 | 127 | 129 | 87 | 148 | 134 |
| Cash Conversion Cycle | 102 | 171 | 184 | 197 | 211 | 177 | 149 | 185 | 208 | 204 | 234 | 169 |
| Working Capital Days | 53 | 92 | 104 | 134 | 116 | 77 | 61 | 84 | 86 | 78 | 88 | 60 |
| ROCE % | 31% | 25% | 23% | 22% | 25% | 30% | 31% | 31% | 34% | 34% | 25% | 29% |
Insights
In beta| Dec 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Better Life Farming (BLF) Centers Number |
|
||||||||
| Agro Chemicals / Crop Protection Turnover Contribution % |
|||||||||
| Smallholder Farmers Reached Million |
|||||||||
| Hybrids and Seeds Turnover Contribution % |
|||||||||
| Innovation Contribution to Total Business % |
|||||||||
| Active Distributors (Dealers) Number |
|||||||||
| Corn Seed Market Position Rank |
|||||||||
| Bayer Direct Seeded Rice (DSR) Acres Acres |
|||||||||
| R&D Expenditure (Percentage of Turnover) % |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - As per Regulation 47 of SEBI Listing Regulations 2015, please find attached the newspaper publication for the audited financial results of the Company for the …
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Bayer CropScience filed FY2025-26 secretarial compliance report confirming full SEBI compliance.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
26 May - Bayer CropScience reported FY26 revenue ₹56,750 million, PBT ₹8,549 million, and recommended ₹60 final dividend.
-
Corporate Action-Board to consider Dividend
26 May - Board approved FY2026 audited results and recommended final dividend of Rs. 60 per share.
-
Audited Results For The Financial Year Ended March 31, 2026
26 May - Bayer CropScience reported FY26 audited results, approved May 26, 2026, and recommended ₹60 final dividend.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Nov 2025Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2023Transcript PPT
-
Jun 2022Transcript PPT
-
Nov 2021Transcript PPT
-
May 2021TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
May 2020TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Jun 2018TranscriptAI SummaryPPT
-
Aug 2017TranscriptAI SummaryPPT
-
Feb 2017TranscriptAI SummaryPPT
-
Jul 2016TranscriptAI SummaryPPT
-
Nov 2015TranscriptAI SummaryPPT
History[1]
The Bayer group launched its Indian operations in 1958 by setting up an agrochemical manufacturing unit, in which the group has 68.58% stake. Company manufactures and markets crop protection solutions, and trades in seeds on behalf of Bayer Bioscience Pvt Ltd.